The market was clearly happy with Milton's announcement today. Share price closed at $16.12 (up 2.8%) - its highest closing price since 18.11.08.
NEU Neuren Pharmaceuticals dips after pediatric Angelman Syndrome Phase 2 trial results fail to impress
Week 32 Wrap: AI is clearly overhyped – but did we see ‘bubble’ burst already? Plus RBA decision; Japan’s wild week & Google ruling